查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497634

β干扰素市场：按类型、给药途径、应用和分销管道划分 - 2024-2030 年全球预测

Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B), Route of Administration (Intramuscular, Intravenous, Subcutaneous), Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年β干扰素市场规模为34.4亿美元，预计2024年将达36.2亿美元，2030年将达51.1亿美元，复合年增长率为5.83%。

β干扰素是一种天然存在于人体内的蛋白质，在免疫系统抵抗感染疾病和疾病方面发挥重要作用。它们被归类为细胞激素，是免疫系统广泛用于细胞间通讯的一组讯号蛋白的一部分。用于治疗多发性硬化症（MS），一种使人衰弱的神经系统疾病。 β干扰素可减少发炎和復发频率，并改善多发性硬化症患者的病程。全球诊断出多发性硬化症的患者数量不断增加，对有效治疗方案的需求正在推动市场发展。此外，旨在传播多发性硬化症及其治疗方案知识的宣传计划和全球健康倡议正在刺激市场需求。然而，与β干扰素相关的副作用，例如类流感症状、部位反应和潜在的肝损伤，可能会阻止一些患者选择这种治疗。此外，旨在提高β-干扰素製剂的功效并减少副作用的持续研究和开发对公司来说是一个充满希望的机会。开拓多发性硬化症以外的新治疗应用，并扩展到医疗需求未满足的新兴国家，是β干扰素市场相关人员的重要成长槓桿。

主要市场统计
基准年[2023] 34.4亿美元
预测年份 [2024] 36.2亿美元
预测年份 [2030] 51.1亿美元
复合年增长率（%） 5.83%

区域洞察

在美洲，特别是在美国和加拿大，多发性硬化症盛行率的上升以及患者寻求有效且安全的治疗方法来控制症状和减缓疾病进展正在推动β干扰素市场的发展。该地区最近的专利集中在改进β-干扰素配方，透过减少剂量次数来提高患者的依从性。还有对个人化医疗的投资，试图根据个人的基因组成客製化治疗方法，这可以提高β-干扰素治疗的有效性。同时，欧洲、中东和非洲市场多元化，各国的报销政策差异很大，但整体而言有利于多发性硬化症治疗。欧洲药品管理局 (EMA) 积极核准创新的给药方案和配方，以确保更好的结果并提高患者的依从性。该地区的一项新专利旨在减少与β干扰素相关的副作用，从而提高患者的生活品质。在亚太地区，β干扰素市场正稳定成长。这一趋势在很大程度上是由于人们对多发性硬化症及其症状的认识不断提高以及改善治疗机会的综合医疗保健政策所推动的。中国、日本和澳洲等国家凭藉其先进的医疗保健系统和不断增加的医学研究投资，在该区域市场中占据重要地位。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在 Beta干扰素市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对 Beta干扰素市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在β干扰素市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中自体免疫疾病盛行率上升
      • 提高免疫疾病的医疗保健意识和努力
      • 改善国家医疗基础设施和支出
    • 抑制因素
      • 部分医疗案例β干扰素效率低、高成本的问题
    • 机会
      • 为多发性硬化症患者进行先进个人化疾病管理的强大研究工作
      • 开发技术主导的疾病诊断平台
    • 任务
      • 与 β干扰素产品相关的严格且漫长的核准流程
  • 市场区隔分析
    • 类型：在多发性硬化症病例中根据需要使用β型干扰素 1A 和 β 1B
    • 应用：增加β干扰素在治疗免疫感染疾病的应用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 β干扰素市场：依类型

  • β型干扰素β1A
  • β型干扰素β1B

第七章 β干扰素市场：依给药途径

  • 肌肉注射
  • 静脉
  • 皮下的

第八章 β干扰素市场：依应用分类

  • 抗病毒作用
  • 免疫调节作用

第 9 章 β干扰素市场：按通路

  • 医院药房
  • 网路药房

第10章 美洲β干扰素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区β干扰素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲β-干扰素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 罗氏製药印度公司宣布推出治疗多发性硬化症的新型单株抗体“Ocrevus”
    • Nona Bioscience 与 Boost Immune 结成策略联盟，加速癌症治疗创新
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-521BAA36EA1C

[195 Pages Report] The Beta Interferon Market size was estimated at USD 3.44 billion in 2023 and expected to reach USD 3.62 billion in 2024, at a CAGR 5.83% to reach USD 5.11 billion by 2030.

Beta interferon is a type of protein that naturally occurs in the human body and plays an important role in the immune system, to fight off infections and diseases. It is classified as a cytokine, which means it is part of the signaling proteins widely used by the immune system to communicate between cells. It is used in the treatment of multiple sclerosis (MS), a debilitating neurological condition. Beta Interferon helps reduce inflammation and the frequency of relapses in MS patients, thereby modifying the disease course. The rising number of diagnosed MS cases globally drives demand for effective treatment options, boosting the market. In addition, awareness programs and global health initiatives to spread knowledge about multiple sclerosis and its treatment options stimulate market demand. However, the side effects associated with beta interferon, such as flu-like symptoms, site reactions, and potential liver damage, may deter some patients from opting for this treatment. Moreover, ongoing research and development activities aimed at enhancing the efficacy and lowering the adverse effects of beta interferon preparations present promising opportunities for companies. Exploring novel therapeutic applications beyond multiple sclerosis and expanding into emerging economies with unmet medical needs present significant growth avenues for stakeholders in the beta interferon market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.44 billion
Estimated Year [2024] USD 3.62 billion
Forecast Year [2030] USD 5.11 billion
CAGR (%) 5.83%

Regional Insights

In the Americas, particularly in the United States and Canada, the beta interferon market is driven by the rising prevalence of MS, with patients seeking effective and safer therapies that can manage symptoms and delay disease progression. Recent patents in this region have focused on improvements in Beta Interferon formulations that enhance patient adherence by reducing the frequency of doses. Investments are also being channeled toward personalized medicine, which attempts to tailor treatments to the individual's genetic composition, potentially increasing the efficacy of beta-interferon therapies. At the same time, the EMEA market is diverse, with reimbursement policies varying significantly across countries, but they are generally favorable towards MS treatments. The European Medicines Agency (EMA) has proactively approved innovative dosing regimens and formulations that promise better outcomes or enhanced patient compliance. New patents in the region have aimed at reducing side effects associated with Beta Interferon, thereby improving the quality of life for patients. In the Asia Pacific region, the market for beta interferon is experiencing steady growth. This trend is largely driven by increasing awareness about MS and its symptoms, coupled with more comprehensive healthcare policies that are improving access to treatments. Countries such as China, Japan, and Australia are significant in the regional market due to their advanced healthcare systems and increasing investment in medical research.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Beta Interferon Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of autoimmune diseases among population
      • Growing healthcare awareness and initiatives for immune disorders
      • Improved healthcare infrastructure and spending across economies
    • Market Restraints
      • Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
    • Market Opportunities
      • Robust research activities to advanced individualized disease management for people living with multiple sclerosis
      • Development of technology-driven platforms for disease diagnosis
    • Market Challenges
      • Stringent and time consuming approval processes associated with beta interferon products
  • Market Segmentation Analysis
    • Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
    • Application: Increasing usage of beta interferon to treat immuno infectious diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Beta Interferon Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Beta Interferon Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis

Roche Pharma India, part of the global Swiss pharmaceutical conglomerate Roche, officially launched Ocrevus (ocrelizumab) in the Indian market, offering new hope to the 150,000-200,000 patients diagnosed with multiple sclerosis (MS) in the country. This biannual, two-hour infusion therapy marks a significant advancement over existing treatments by specifically targeting CD20+ B cells, which are implicated in the aggressive progression of MS by damaging the myelin sheath of nerve fibers. [Published On: 2024-02-27]

Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations

Nona Biosciences entered a collaboration with Boostimmune, a company focused on advanced anti-cancer therapies. This partnership aims to utilize Nona Biosciences' proprietary Harbour Mice H2L2 platform, which produces fully human monoclonal antibodies, to develop cutting-edge Antibody-Drug Conjugates (ADCs) aimed at novel cancer targets. With its extensive experience in antibody discovery and development, Nona Biosciences supports projects from conception to Investigational New Drug (IND) application, ensuring a comprehensive integration of services to foster significant advancements in cancer treatment. [Published On: 2024-02-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Beta Interferon Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Beta Interferon Market, highlighting leading vendors and their innovative profiles. These include Amega Biotech, Avantor, Inc., Bayer AG, Biogen Inc., BioLegend, Inc. by PerkinElmer Inc., Biosidus S.A, F. Hoffmann La-Roche Ltd., Faron Pharmaceuticals, Heligenics, Inc., Merck KGaA, Novartis AG, OriGene Technologies, Inc., Pfizer Inc., Qiagen GmbH, Sino Biological, Inc., Synairgen PLC, Thermo Fisher Scientific Inc., and Xiamen Amoytop Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Beta Interferon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Interferon Beta-1A
    • Interferon Beta-1B
  • Route of Administration
    • Intramuscular
    • Intravenous
    • Subcutaneous
  • Application
    • Antiviral Effects
    • Immunomodulatory Effects
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of autoimmune diseases among population
      • 5.1.1.2. Growing healthcare awareness and initiatives for immune disorders
      • 5.1.1.3. Improved healthcare infrastructure and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research activities to advanced individualized disease management for people living with multiple sclerosis
      • 5.1.3.2. Development of technology-driven platforms for disease diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes associated with beta interferon products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
    • 5.2.2. Application: Increasing usage of beta interferon to treat immuno infectious diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Beta Interferon Market, by Type

  • 6.1. Introduction
  • 6.2. Interferon Beta-1A
  • 6.3. Interferon Beta-1B

7. Beta Interferon Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Intramuscular
  • 7.3. Intravenous
  • 7.4. Subcutaneous

8. Beta Interferon Market, by Application

  • 8.1. Introduction
  • 8.2. Antiviral Effects
  • 8.3. Immunomodulatory Effects

9. Beta Interferon Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies

10. Americas Beta Interferon Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Beta Interferon Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Beta Interferon Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis
    • 13.3.2. Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BETA INTERFERON MARKET RESEARCH PROCESS
  • FIGURE 2. BETA INTERFERON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BETA INTERFERON MARKET DYNAMICS
  • FIGURE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BETA INTERFERON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BETA INTERFERON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BETA INTERFERON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BETA INTERFERON MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES BETA INTER